Who Is Gene-TEK™ For?

Gene-TEK™ supports diverse and complex clinical cases.

Diagnostic Challenges
Diagnostic Challenges

Patients with negative exome results who still lack a diagnosis.

Unclear Hereditary Patterns
Unclear Hereditary Patterns

Families where hereditary conditions span generations but remain unidentified by standard testing.

Health Assessment Programs
Health Assessment Programs

Healthcare programs requiring complete genomic profiling of their patients.

What is Gene-TEK™?

The Ultimate Genomic Blueprint

Gene-TEK™ is designed primarily for the diagnosis of complex and unresolved genetic conditions. Beyond its core diagnostic power, it also delivers comprehensive coverage across a broad range of additional genomic areas:

Hereditary cancer screening
Hereditary cancer screening

Solid tumors and hematopoietic malignancies across high-penetrance cancer predisposition genes.

Clinically actionable hereditary conditions
Clinically actionable hereditary conditions

ACMG-recommended and institutionally prioritized findings with clear management implications.

Carrier screening
Carrier screening

Serious recessive and X-linked disorders relevant to reproductive planning and family history.

Pharmacogenomic profiling
Pharmacogenomic profiling

Extensive PGx coverage to support medication selection and dosing across major drug classes.

Polygenic risk scores
Polygenic risk scores

PRS for 19 common diseases to complement monogenic findings in preventive care planning.

Structural variation HLA
Structural variation & HLA

Copy-number changes and detailed HLA analysis for immunogenetics and advanced drug response.

Precision Medicine

Why Should You Choose Gene-TEK™?

The Complete Picture: Gene-TEK™ analyzes both coding and non-coding regulatory regions, identifying structural variants that are invisible to exome or panel testing.

Clinic-Led Customization: We partner with clinics to allow for customized test configurations. Whether a clinic is interested in specific metabolic pathways or unique neurological markers, Virotek can adapt the Gene-TEK™ analysis to meet those institutional goals.

Future-Proof Health: Data can be reanalyzed as knowledge advances, without treating the test as useful only once.

For Healthcare Providers

Clinical Utility & Implementation Tips

Gene-TEK™ provides clinicians with a high-yield diagnostic tool for rare and undiagnosed conditions. To maximize the effectiveness of Whole Genome Sequencing (WGS) in your clinic, we suggest the following strategies:

  • Standardized Phenotype Documentation: Use consistent, detailed tools to document clinical features — accurate phenotyping significantly improves variant prioritization and interpretation.

  • Established Counseling Protocols: Implement a formal pre-test counseling protocol to ensure patients understand the test’s scope, including the potential for incidental findings.

  • Specialist Referral Pathways: Establish clear referral pathways to genetics specialists for patients who receive complex or pathogenic findings.

  • Periodic Data Reanalysis: Consider reanalyzing genome data every 1–2 years, as evolving medical knowledge may yield new answers even after an initial negative result.

Clinical utility and implementation
Process

How It Works

From sample to clinically annotated whole-genome report.

How Gene-TEK works

Ready to Integrate Gene-TEK™ Into Your Practice?

Contact our team to learn how our tests can enhance your clinical offerings and improve patient outcomes.

Contact Sales Request Information